<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38359079</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>Enterovirus A71 does not meet the uncoating receptor SCARB2 at the cell surface.</ArticleTitle><Pagination><StartPage>e1012022</StartPage><MedlinePgn>e1012022</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1012022</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1012022</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) infection involves a variety of receptors. Among them, two transmembrane protein receptors have been investigated in detail and shown to be critical for infection: P-selectin glycoprotein ligand-1 (PSGL-1) in lymphocytes (Jurkat cells), and scavenger receptor class B member 2 (SCARB2) in rhabdomyosarcoma (RD) cells. PSGL-1 and SCARB2 have been reported to be expressed on the surface of Jurkat and RD cells, respectively. In the work reported here, we investigated the roles of PSGL-1 and SCARB2 in the process of EV-A71 entry. We first examined the expression of SCARB2 in Jurkat cells, and detected it within the cytoplasm, but not on the cell surface. Further, using PSGL-1 and SCARB2 knockout cells, we found that although both PSGL-1 and SCARB2 are essential for virus infection of Jurkat cells, virus attachment to these cells requires only PSGL-1. These results led us to evaluate the cell surface expression and the roles of SCARB2 in other EV-A71-susceptible cell lines. Surprisingly, in contrast to the results of previous studies, we found that SCARB2 is absent from the surface of RD cells and other susceptible cell lines we examined, and that although SCARB2 is essential for infection of these cells, it is dispensable for virus attachment. These results indicate that a receptor other than SCARB2 is responsible for virus attachment to the cell and probably for internalization of virions, not only in Jurkat cells but also in RD cells and other EV-A71-susceptible cells. SCARB2 is highly concentrated in lysosomes and late endosomes, where it is likely to trigger acid-dependent uncoating of virions, the critical final step of the entry process. Our results suggest that the essential interactions between EV-A71 and SCARB2 occur, not at the cell surface, but within the cell.</AbstractText><CopyrightInformation>Copyright: Â© 2024 Nishimura et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nishimura</LastName><ForeName>Yorihiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0007-7561-8509</Identifier><AffiliationInfo><Affiliation>Department of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Kei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koyanagi</LastName><ForeName>Yoshio</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakita</LastName><ForeName>Takaji</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muramatsu</LastName><ForeName>Masamichi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease Research, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe-shi, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergelson</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arita</LastName><ForeName>Minetaro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI072490</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI111285</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074299">SCARB2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051116">Receptors, Scavenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosomal Membrane Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051116" MajorTopicYN="N">Receptors, Scavenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="N">Lysosomal Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>15</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>15</Day><Hour>13</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38359079</ArticleId><ArticleId IdType="pmc">PMC10901359</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1012022</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-23-01110</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kinobe R, Wiyatno A, Artika IM, Safari D. Insight into the Enterovirus A71: A review. Rev Med Virol. 2022:e2361. Epub 20220505. doi: 10.1002/rmv.2361 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2361</ArticleId><ArticleId IdType="pubmed">35510476</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin HY, Gau SS, Lu CY, Hsia SH, Huang YC, et al.. Enterovirus A71 neurologic complications and long-term sequelae. J Biomed Sci. 2019;26(1):57. Epub 20190808. doi: 10.1186/s12929-019-0552-7 ; PubMed Central PMCID:PMC6688366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0552-7</ArticleId><ArticleId IdType="pmc">PMC6688366</ArticleId><ArticleId IdType="pubmed">31395054</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee HK, Zainol MI, Sam IC, Chan YF. Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis. Expert Rev Anti Infect Ther. 2021;19(6):733â47. Epub 20210217. doi: 10.1080/14787210.2021.1851194 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2021.1851194</ArticleId><ArticleId IdType="pubmed">33183118</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Cheng D, Wang JR. Enterovirus A71: virulence, antigenicity, and genetic evolution over the years. J Biomed Sci. 2019;26(1):81. Epub 20191021. doi: 10.1186/s12929-019-0574-1 ; PubMed Central PMCID:PMC6802317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0574-1</ArticleId><ArticleId IdType="pmc">PMC6802317</ArticleId><ArticleId IdType="pubmed">31630680</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J Biomed Sci. 2019;26(1):75. Epub 20191018. doi: 10.1186/s12929-019-0573-2 ; PubMed Central PMCID:PMC6798416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0573-2</ArticleId><ArticleId IdType="pmc">PMC6798416</ArticleId><ArticleId IdType="pubmed">31627753</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas-Alba D, de Sevilla MF, Valero-Rello A, Fortuny C, GarcÃ­a-GarcÃ­a JJ, Ortez C, et al.. Outbreak of brainstem encephalitis associated with enterovirus-A71 in Catalonia, Spain (2016): a clinical observational study in a childrenâs reference centre in Catalonia. Clin Microbiol Infect. 2017;23(11):874â81. Epub 20170323. doi: 10.1016/j.cmi.2017.03.016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2017.03.016</ArticleId><ArticleId IdType="pubmed">28344164</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Spence-Davizon E, Osborne C, Press C, Schreiner TL, Martin J, et al.. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study. Lancet Infect Dis. 2020;20(2):230â9. Epub 20191216. doi: 10.1016/S1473-3099(19)30632-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30632-2</ArticleId><ArticleId IdType="pmc">PMC11284833</ArticleId><ArticleId IdType="pubmed">31859216</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794â7. Epub 20090621. doi: 10.1038/nm.1961 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, et al.. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15(7):798â801. Epub 20090621. doi: 10.1038/nm.1992 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N, Cong H, Tian H, Zhang H, Zhang W, Song L, et al.. Cell surface vimentin is an attachment receptor for enterovirus 71. J Virol. 2014;88(10):5816â33. Epub 20140312. doi: 10.1128/JVI.03826-13 ; PubMed Central PMCID:PMC4019121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>He QQ, Ren S, Xia ZC, Cheng ZK, Peng NF, Zhu Y. Fibronectin facilitates enterovirus 71 infection by mediating viral entry. J Virol. 2018;92(9). Epub 20180413. doi: 10.1128/JVI.02251-17 ; PubMed Central PMCID:PMC5899198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02251-17</ArticleId><ArticleId IdType="pmc">PMC5899198</ArticleId><ArticleId IdType="pubmed">29467312</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing J, Wang Y, Sun Y, Huang J, Yan W, Wang J, et al.. Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator. PLoS Pathog. 2014;10(10):e1004422. Epub 20141002. doi: 10.1371/journal.ppat.1004422 ; PubMed Central PMCID:PMC4183573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004422</ArticleId><ArticleId IdType="pmc">PMC4183573</ArticleId><ArticleId IdType="pubmed">25275585</ArticleId></ArticleIdList></Reference><Reference><Citation>Su PY, Wang YF, Huang SW, Lo YC, Wang YH, Wu SR, et al.. Cell surface nucleolin facilitates enterovirus 71 binding and infection. J Virol. 2015;89(8):4527â38. Epub 20150211. doi: 10.1128/JVI.03498-14 ; PubMed Central PMCID:PMC4442404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam IC, Chan YF. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol. 2013;87(1):611â20. Epub 20121024. doi: 10.1128/JVI.02226-12 ; PubMed Central PMCID:PMC3536405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Too IHK, Bonne I, Tan EL, Chu JJH, Alonso S. Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis. PLoS Pathog. 2018;14(1):e1006778. Epub 20180111. doi: 10.1371/journal.ppat.1006778 ; PubMed Central PMCID:PMC5764453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006778</ArticleId><ArticleId IdType="pmc">PMC5764453</ArticleId><ArticleId IdType="pubmed">29324904</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J. 2009;6:141. Epub 20090915. doi: 10.1186/1743-422X-6-141 ; PubMed Central PMCID:PMC2751754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol. 2011;85(22):11809â20. Epub 20110907. doi: 10.1128/JVI.00297-11 ; PubMed Central PMCID:PMC3209289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung ML, Jia L, Yip CCY, Chan JFW, Teng JLL, Chan KH, et al.. Human tryptophanyl-tRNA synthetase is an IFN-Î³-inducible entry factor for Enterovirus. J Clin Invest. 2018;128(11):5163â77. Epub 20181015. doi: 10.1172/jci99411 ; PubMed Central PMCID:PMC6205371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci99411</ArticleId><ArticleId IdType="pmc">PMC6205371</ArticleId><ArticleId IdType="pubmed">30153112</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Wakita T, Shimizu H. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog. 2010;6(11):e1001174. Epub 20101104. doi: 10.1371/journal.ppat.1001174 ; PubMed Central PMCID:PMC2973824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001174</ArticleId><ArticleId IdType="pmc">PMC2973824</ArticleId><ArticleId IdType="pubmed">21079683</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Lee H, Hafenstein S, Kataoka C, Wakita T, Bergelson JM, et al.. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 2013;9(7):e1003511. Epub 2013/08/13. doi: 10.1371/journal.ppat.1003511 ; PubMed Central PMCID:PMC3723564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, McLaughlin NP, Pan J, Goldstein S, Hafenstein S, Shimizu H, et al.. The suramin derivative NF449 interacts with the 5-fold vertex of the enterovirus A71 capsid to prevent virus attachment to PSGL-1 and heparan sulfate. PLoS Pathog. 2015;11(10):e1005184. Epub 2015/10/03. doi: 10.1371/journal.ppat.1005184 ; PubMed Central PMCID:PMC4592248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005184</ArticleId><ArticleId IdType="pmc">PMC4592248</ArticleId><ArticleId IdType="pubmed">26430888</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol. 2011;85(10):4937â46. Epub 20110309. doi: 10.1128/JVI.02358-10 ; PubMed Central PMCID:PMC3126200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol. 2013;87(6):3335â47. Epub 20130109. doi: 10.1128/JVI.02070-12 ; PubMed Central PMCID:PMC3592140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Zhao Y, Kotecha A, Fry EE, Kelly JT, Wang X, et al.. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat Microbiol. 2019;4(3):414â9. Epub 2018/12/12. doi: 10.1038/s41564-018-0319-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Barriocanal JG, Bonifacino JS, Yuan L, Sandoval IV. Biosynthesis, glycosylation, movement through the Golgi system, and transport to lysosomes by an N-linked carbohydrate-independent mechanism of three lysosomal integral membrane proteins. J Biol Chem. 1986;261(35):16755â63. .</Citation><ArticleIdList><ArticleId IdType="pubmed">3782140</ArticleId></ArticleIdList></Reference><Reference><Citation>Reczek D, Schwake M, SchrÃ¶der J, Hughes H, Blanz J, Jin X, et al.. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell. 2007;131(4):770â83. doi: 10.1016/j.cell.2007.10.018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.018</ArticleId><ArticleId IdType="pubmed">18022370</ArticleId></ArticleIdList></Reference><Reference><Citation>Heybrock S, Kanerva K, Meng Y, Ing C, Liang A, Xiong ZJ, et al.. Lysosomal integral membrane protein-2 (LIMP-2/SCARB2) is involved in lysosomal cholesterol export. Nat Commun. 2019;10(1):3521. Epub 20190806. doi: 10.1038/s41467-019-11425-0 ; PubMed Central PMCID:PMC6684646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11425-0</ArticleId><ArticleId IdType="pmc">PMC6684646</ArticleId><ArticleId IdType="pubmed">31387993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Yu SL, Shao HY, Lin HY, Liu CC, Hsiao KN, et al.. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS One. 2013;8(2):e57591. Epub 20130225. doi: 10.1371/journal.pone.0057591 ; PubMed Central PMCID:PMC3581494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057591</ArticleId><ArticleId IdType="pmc">PMC3581494</ArticleId><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, et al.. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci U S A. 2013;110(36):14753â8. Epub 20130819. doi: 10.1073/pnas.1217563110 ; PubMed Central PMCID:PMC3767555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Song Z, Qi Y, Feng X, Xu N, Sun Y, et al.. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem. 2012;287(9):6406â20. Epub 20120104. doi: 10.1074/jbc.M111.301622 ; PubMed Central PMCID:PMC3307280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval IV, Arredondo JJ, Alcalde J, Gonzalez Noriega A, Vandekerckhove J, Jimenez MA, et al.. The residues Leu(Ile)475-Ile(Leu, Val, Ala)476, contained in the extended carboxyl cytoplasmic tail, are critical for targeting of the resident lysosomal membrane protein LIMP II to lysosomes. J Biol Chem. 1994;269(9):6622â31. Epub 1994/03/04. .</Citation><ArticleIdList><ArticleId IdType="pubmed">7509809</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain KM, Leong KL, Ng MM, Chu JJ. The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J Biol Chem. 2011;286(1):309â21. Epub 20101018. doi: 10.1074/jbc.M110.168468 ; PubMed Central PMCID:PMC3012988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.168468</ArticleId><ArticleId IdType="pmc">PMC3012988</ArticleId><ArticleId IdType="pubmed">20956521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohka S, Tan SH, Ishiyama E, Ogasawara K, Hanasaka T, Ishida K, et al.. The uncoating of EV71 in mature late endosomes requires CD-M6PR. Biol Open. 2022;11(9). Epub 20220913. doi: 10.1242/bio.059469 ; PubMed Central PMCID:PMC9493940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/bio.059469</ArticleId><ArticleId IdType="pmc">PMC9493940</ArticleId><ArticleId IdType="pubmed">35929543</ArticleId></ArticleIdList></Reference><Reference><Citation>Laszik Z, Jansen PJ, Cummings RD, Tedder TF, McEver RP, Moore KL. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood. 1996;88(8):3010â21. .</Citation><ArticleIdList><ArticleId IdType="pubmed">8874199</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers WS, Tang J, Shaw GD, Camphausen RT. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell. 2000;103(3):467â79. doi: 10.1016/s0092-8674(00)00138-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)00138-0</ArticleId><ArticleId IdType="pubmed">11081633</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega MA, Rodriguez F, SeguÃ­ B, CalÃ©s C, Alcalde J, Sandoval IV. Targeting of lysosomal integral membrane protein LIMP II. The tyrosine-lacking carboxyl cytoplasmic tail of LIMP II is sufficient for direct targeting to lysosomes. J Biol Chem. 1991;266(25):16269â72. Epub 1991/09/05. .</Citation><ArticleIdList><ArticleId IdType="pubmed">1715864</ArticleId></ArticleIdList></Reference><Reference><Citation>Neculai D, Schwake M, Ravichandran M, Zunke F, Collins RF, Peters J, et al.. Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36. Nature. 2013;504(7478):172â6. Epub 20131027. doi: 10.1038/nature12684 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12684</ArticleId><ArticleId IdType="pubmed">24162852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Ren J, Padilla-Parra S, Fry EE, Stuart DI. Lysosome sorting of Î²-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor. Nat Commun. 2014;5:4321. Epub 20140714. doi: 10.1038/ncomms5321 ; PubMed Central PMCID:PMC4104448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5321</ArticleId><ArticleId IdType="pmc">PMC4104448</ArticleId><ArticleId IdType="pubmed">25027712</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, Sinniah M, et al.. Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997â1998. Jpn J Infect Dis. 1999;52(1):12â5. .</Citation><ArticleIdList><ArticleId IdType="pubmed">10808253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281â308. Epub 2013/10/26. doi: 10.1038/nprot.2013.143 ; PubMed Central PMCID:PMC3969860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.143</ArticleId><ArticleId IdType="pmc">PMC3969860</ArticleId><ArticleId IdType="pubmed">24157548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuronita T, Hatano T, Furuyama A, Hirota Y, Masuyama N, Saftig P, et al.. The NH(2)-terminal transmembrane and lumenal domains of LGP85 are needed for the formation of enlarged endosomes/lysosomes. Traffic. 2005;6(10):895â906. doi: 10.1111/j.1600-0854.2005.00325.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2005.00325.x</ArticleId><ArticleId IdType="pubmed">16138903</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z, Ye X, Shi J, Wang X, Liu Q, Huang Z. Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J Virol. 2015;89(23):12084â95. Epub 2015/09/25. doi: 10.1128/JVI.02189-15 ; PubMed Central PMCID:PMC4645313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02189-15</ArticleId><ArticleId IdType="pmc">PMC4645313</ArticleId><ArticleId IdType="pubmed">26401034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippincott-Schwartz J, Fambrough DM. Cycling of the integral membrane glycoprotein, LEP100, between plasma membrane and lysosomes: kinetic and morphological analysis. Cell. 1987;49(5):669â77. Epub 1987/06/05. doi: 10.1016/0092-8674(87)90543-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(87)90543-5</ArticleId><ArticleId IdType="pubmed">3107839</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Borgne R, Alconada A, Bauer U, Hoflack B. The mammalian AP-3 adaptor-like complex mediates the intracellular transport of lysosomal membrane glycoproteins. J Biol Chem. 1998;273(45):29451â61. Epub 1998/10/29. doi: 10.1074/jbc.273.45.29451 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.45.29451</ArticleId><ArticleId IdType="pubmed">9792650</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodionov DG, HÃ¶ning S, Silye A, Kongsvik TL, von Figura K, Bakke O. Structural requirements for interactions between leucine-sorting signals and clathrin-associated adaptor protein complex AP3. J Biol Chem. 2002;277(49):47436â43. Epub 2002/10/09. doi: 10.1074/jbc.M207149200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207149200</ArticleId><ArticleId IdType="pubmed">12370188</ArticleId></ArticleIdList></Reference><Reference><Citation>Niwa K, Tanaka R, Murase H, Ishikawa T, Fujita H, Himeno M, et al.. Two lysosomal membrane proteins, LGP85 and LGP107, are delivered to late endosomes/lysosomes through different intracellular routes after exiting from the trans-Golgi network. Biochem Biophys Res Commun. 2003;301(4):833â40. Epub 2003/02/19. doi: 10.1016/s0006-291x(03)00046-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0006-291x(03)00046-9</ArticleId><ArticleId IdType="pubmed">12589788</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo D, Yu X, Wang D, Li Z, Zhou Y, Xu G, et al.. SLC35B2 acts in a dual role in the host sulfation required for EV71 infection. J Virol. 2022;96(9):e0204221. Epub 20220414. doi: 10.1128/jvi.02042-21 ; PubMed Central PMCID:PMC9093107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02042-21</ArticleId><ArticleId IdType="pmc">PMC9093107</ArticleId><ArticleId IdType="pubmed">35420441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Mizuta K, Koike S. Heparan sulfate attachment receptor is a major selection factor for attenuated enterovirus 71 mutants during cell culture adaptation. PLoS Pathog. 2020;16(3):e1008428. Epub 20200318. doi: 10.1371/journal.ppat.1008428 ; PubMed Central PMCID:PMC7105141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008428</ArticleId><ArticleId IdType="pmc">PMC7105141</ArticleId><ArticleId IdType="pubmed">32187235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HY, Yang YT, Yu SL, Hsiao KN, Liu CC, Sia C, et al.. Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection. J Virol. 2013;87(16):9064â76. Epub 20130612. doi: 10.1128/JVI.00573-13 ; PubMed Central PMCID:PMC3754029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00573-13</ArticleId><ArticleId IdType="pmc">PMC3754029</ArticleId><ArticleId IdType="pubmed">23760234</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson JM, Coyne CB. Picornavirus entry. Adv Exp Med Biol. 2013;790:24â41. doi: 10.1007/978-1-4614-7651-1_2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-7651-1_2</ArticleId><ArticleId IdType="pubmed">23884584</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruokolainen V, MarjomÃ¤ki V. Enterovirus entry and uncoating. In: Tang YW, Hindiyeh M, Liu D, Sails A, Spearman P, Zhang JR, editors. Molecular Medical Microbiology. 3 ed: Academic Press; 2023. pp. 2085â102.</Citation></Reference><Reference><Citation>Coyne CB, Bergelson JM. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell. 2006;124(1):119â31. doi: 10.1016/j.cell.2005.10.035 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.10.035</ArticleId><ArticleId IdType="pubmed">16413486</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Zhang G, Liu S, Chen X, Peng R, Dai L, et al.. Human Neonatal Fc Receptor Is the Cellular Uncoating Receptor for Enterovirus B. Cell. 2019;177(6):1553â65.e16. Epub 20190516. doi: 10.1016/j.cell.2019.04.035 ; PubMed Central PMCID:PMC7111318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.04.035</ArticleId><ArticleId IdType="pmc">PMC7111318</ArticleId><ArticleId IdType="pubmed">31104841</ArticleId></ArticleIdList></Reference><Reference><Citation>Morosky S, Wells AI, Lemon K, Evans AS, Schamus S, Bakkenist CJ, et al.. The neonatal Fc receptor is a pan-echovirus receptor. Proc Natl Acad Sci U S A. 2019;116(9):3758â63. Epub 20190211. doi: 10.1073/pnas.1817341116 ; PubMed Central PMCID:PMC6397586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1817341116</ArticleId><ArticleId IdType="pmc">PMC6397586</ArticleId><ArticleId IdType="pubmed">30808762</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Koike S. Cellular receptors for enterovirus A71. J Biomed Sci. 2020;27(1):23. Epub 2020/01/12. doi: 10.1186/s12929-020-0615-9 ; PubMed Central PMCID:PMC6954530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Jae LT, Brummelkamp TR. Emerging intracellular receptors for hemorrhagic fever viruses. Trends Microbiol. 2015;23(7):392â400. Epub 20150521. doi: 10.1016/j.tim.2015.04.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2015.04.006</ArticleId><ArticleId IdType="pubmed">26004032</ArticleId></ArticleIdList></Reference><Reference><Citation>Capes-Davis A, Theodosopoulos G, Atkin I, Drexler HG, Kohara A, MacLeod RA, et al.. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer. 2010;127(1):1â8. doi: 10.1002/ijc.25242 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.25242</ArticleId><ArticleId IdType="pubmed">20143388</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanabe H, Takada Y, Minegishi D, Kurematsu M, Masui T, Mizusawa H. Cell line individualization by STR multiplex system in the cell bank found cross-contamination between ECV304, and EJ-1/T24. Tiss Cult Res Commun. 1999;18:329â38.</Citation></Reference><Reference><Citation>Izumiya Y, Lin SF, Ellison T, Chen LY, Izumiya C, Luciw P, et al.. Kaposiâs sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. J Virol. 2003;77(2):1441â51. doi: 10.1128/jvi.77.2.1441-1451.2003 ; PubMed Central PMCID:PMC140808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.77.2.1441-1451.2003</ArticleId><ArticleId IdType="pmc">PMC140808</ArticleId><ArticleId IdType="pubmed">12502859</ArticleId></ArticleIdList></Reference><Reference><Citation>Spearman C. The method of âright and wrong casesâ (âconstant stimuliâ) without Gaussâs formulae. Br J Psychol. 1908;2(3):227â42. doi: 10.1111/j.2044-8295.1908.tb00176.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8295.1908.tb00176.x</ArticleId></ArticleIdList></Reference><Reference><Citation>KÃ¤rber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Archiv f experiment Pathol u Pharmakol 1931;162:480â3. doi: 10.1007/BF01863914</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01863914</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, et al.. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature. 2016;529(7587):490â5. Epub 2016/01/07. doi: 10.1038/nature16526 ; PubMed Central PMCID:PMC4851738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature16526</ArticleId><ArticleId IdType="pmc">PMC4851738</ArticleId><ArticleId IdType="pubmed">26735016</ArticleId></ArticleIdList></Reference><Reference><Citation>Naito Y, Hino K, Bono H, Ui-Tei K. CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites. Bioinformatics. 2015;31(7):1120â3. Epub 2014/11/22. doi: 10.1093/bioinformatics/btu743 ; PubMed Central PMCID:PMC4382898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu743</ArticleId><ArticleId IdType="pmc">PMC4382898</ArticleId><ArticleId IdType="pubmed">25414360</ArticleId></ArticleIdList></Reference><Reference><Citation>Durocher Y, Perret S, Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 2002;30(2):E9. doi: 10.1093/nar/30.2.e9 ; PubMed Central PMCID:PMC99848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/30.2.e9</ArticleId><ArticleId IdType="pmc">PMC99848</ArticleId><ArticleId IdType="pubmed">11788735</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al.. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676â82. Epub 2012/06/30. doi: 10.1038/nmeth.2019 ; PubMed Central PMCID:PMC3855844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson N, Gullberg M, Lindberg AM. Real-time polymerase chain reaction as a rapid and efficient alternative to estimation of picornavirus titers by tissue culture infectious dose 50% or plaque forming units. Microbiol Immunol. 2009;53(3):149â54. doi: 10.1111/j.1348-0421.2009.00107.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2009.00107.x</ArticleId><ArticleId IdType="pubmed">19302525</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>